CClinicalTrials.gg
Active, not recruitingNCT07267858COPD_CPilatesUpdated Dec 5, 2025

Clinical Pilates Programme on People With COPD Gold A: a Rehabilitation Nursing Approach.

An interventional study of Clinical Pilates for people with COPD Gold A. in COPD (Chronic Obstructive Pulmonary Disease), sponsored by University of Trás-os-Montes and Alto Douro. Active, not recruiting at 1 site in Portugal. Open to participants aged 40 Years to 80 Years. Per ClinicalTrials.gov, last updated 2025-12-05.

Sponsored by University of Trás-os-Montes and Alto Douro · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year after the study started (first participant enrolled Nov 2024, registered Nov 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
38
Allocation
Randomized
Ages
40 Years to 80 Years
Sex
All
01

Study summary

The main objective of this study is to evaluate the effects of a Clinical Pilates-based exercise programme on chest mobility, lung function, motor performance, physical activity levels, sleep quality and Health-Related Quality of Life (HRQoL) in individuals with Gold A COPD. Based on our research question, 'What is the effect of a Clinical Pilates programme on thoracic mobility, pulmonary function, motor performance, physical activity levels, sleep quality, and HRQoL in people with Gold A COPD?', we propose the following research hypotheses:

H1: The Clinical Pilates programme contributed to improved thoracic mobility in people with Gold A COPD.

H2: The Clinical Pilates programme contributed to improved lung function in people with Gold A COPD.

H3: The Clinical Pilates programme positively influences the motor performance of people with Gold A COPD.

H4: The Clinical Pilates programme positively influences the physical activity levels of people with COPD Gold A.

H5: The Clinical Pilates programme positively influences the sleep quality of people with COPD Gold A.

H6: The Clinical Pilates programme contributes to improving the HRQoL levels of people with COPD Gold A.

02

Conditions studied

  • COPD (Chronic Obstructive Pulmonary Disease)

Keywords

  • COPD
  • Clinical Pilates
  • Rehabilitation Nursing
03

In context

Pulmonary Disease, Chronic Obstructive

4,131 studies on the registry are indexed under Pulmonary Disease, Chronic Obstructive; 697 are open to participants now.

This study's enrollment of 38 is below the median of 70 across 2,926 interventional studies indexed under Pulmonary Disease, Chronic Obstructive.

Browse Pulmonary Disease, Chronic Obstructive studies →

Lead sponsor

University of Trás-os-Montes and Alto Douro is the lead sponsor of 10 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Anyone diagnosed with COPD at GOLD stage A, duly identified in SClínico, registered with the USF and residing in the geographical area covered by the Guimarães UCC, whose participation is validated by their family doctor. Inclusion in the study implies participation in at least 60% of the programme sessions, namely 10.

Exclusion criteria

Exclusion Criteria:

  • People with a history of exacerbation of the disease less than 4 weeks ago, as the guidelines of the European Respiratory Society and the American Thoracic Society (2017) make a conditional recommendation on pulmonary rehabilitation after exacerbation and recommend waiting at least 3 weeks, severe osteoarticular limitation that prevents physical exercise, psychiatric illness or severe cognitive dysfunction, unstable comorbidities such as unstable ischaemic disease or decompensated heart failure, and exercise-induced hypoxemia refractory to oxygen administration.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
38 participants (actual)

Study arms

  • Experimental
    Clinical Pilates Group (CPG)

    Group of individuals with ongoing rehabilitation nursing consultations who participate in the CP programme consisting of 16 sessions of 60 minutes each.

    Behavioral: Clinical Pilates for people with COPD Gold A.

  • No intervention
    Control Group (CG)

    Group that only underwent follow-up rehabilitation nursing consultations.

Interventions

  • BehavioralClinical Pilates for people with COPD Gold A.

    8-week programme with face-to-face sessions twice a week, lasting approximately 60 minutes per session, using equipment such as soft balls and elastic bands.

06

What researchers measure

Primary outcomes

  1. Effect of a Clinical Pilates programme, as a tool in the field of Rehabilitation Nursing, on thoracic mobility in people with COPD Gold A.

    Chirometric tests of the Thorax (Lanza et al., 2013). * The person stands with their hands on their hips, chest bare, with the investigator in front of them; * A tape measure is placed over the patient's rib cage in the axillary region; * The zero point of the tape measure is fixed in the anterior region of the chest at each level: axillary, with the tape passing through the axillary fold, and xiphoid, with the tape fixed to the xiphoid process. The other end of the tape goes around the chest and is pulled by the examiner over this fixed point, exerting as little pressure as possible on the person's body (the tape is adjusted but not tightened, ensuring that the contour of the soft tissues remains unchanged). * The person is asked to take a maximum breath in, followed by a maximum breath out, holding each for at least 2 seconds. * The measurement (cm) is recorded at the end of the breath out and the breath in. * The measurement is repeated.

    Time frame: Applied pre-intervention and post-intervention (with a 2-month interval). Both in Experimental and control group.

  2. Effect of a Clinical Pilates programme, as a tool in the field of Rehabilitation Nursing on pulmonary function in people with COPD Gold A.

    Peak expiratory flow - Peak Flow (Miler et al., 2005). * The person sits with their neck in a neutral position, looking straight ahead; * They hold the Peak Flow meter and place it close to their mouth (ensuring that the indicator needle is set at 0); * The person takes a deep breath, places the Peak Flow in their mouth, between their teeth and with their tongue under the mouthpiece, and blows as hard as possible without pausing; * The highest value of at least three readings is recorded, with only readings that do not differ by more than 20L/min being considered; * Invalidate the result in case of excess saliva in the mouthpiece or coughing during exhalation; * The measurement range is between 50-800 L/min in accordance with the applicable standard ISO 23747:2015.

    Time frame: Applied pre-intervention and post-intervention (with a 2-month interval). Both in Experimental and control group.

  3. Effect of a Clinical Pilates programme, as a tool in the field of Rehabilitation Nursing on motor performance in people with COPD Gold A.

    One-minute sit-to-stand test (Vaidya et al., 2016) and modified Borg scale (Borg, 1982). * The person sits on a chair leaning against the wall, with knees and hips bent at 90º, feet flat on the floor and hands resting on their legs; * The person is asked to stand up and sit down from the chair as quickly as possible without support for one minute. * The number of repetitions is counted. * At the end, the 'Modified Borg Scale' is applied. * The scale is placed in front of the person and they are asked to rate the degree of dyspnoea they perceive. * The rating ranges from 0 to 10, with 0 being 'No shortness of breath' and 10 being 'Maximum shortness of breath'. * The person indicates the number corresponding to the dyspnoea they feel.

    Time frame: Applied pre-intervention and post-intervention (with a 2-month interval). Both in Experimental and control group.

  4. Effect of a Clinical Pilates programme, as a tool in the field of Rehabilitation Nursing on physical activity levels in people with COPD Gold A.

    Actigraph® GT3X+ accelerometer. The brand protocol requires wearing the device for a period of 4 days, including 2 days at the weekend. The device will be programmed for 6 hours on the first day of assessment and recordings will be made every 15 seconds. A record sheet will be provided to indicate the times when the accelerometer is put on and taken off. The device is placed on the non-dominant wrist and daily recording of at least 600 minutes (10 hours) is mandatory.

    Time frame: Applied pre-intervention and post-intervention (with a 2-month interval). Both in Experimental and control group.

  5. Effect of a Clinical Pilates programme, as a tool in the field of Rehabilitation Nursing on sleep quality in people with COPD Gold A.

    The brand protocol requires wearing the device for a period of 4 days, including 2 days at the weekend. The device will be programmed for 6 hours on the first day of assessment and recordings will be made every 15 seconds. A record sheet will be provided to indicate the times when the accelerometer is put on and taken off. The device is placed on the non-dominant wrist and daily recording of at least 600 minutes (10 hours) is mandatory.

    Time frame: Applied pre-intervention and post-intervention (with a 2-month interval). Both in Experimental and control group.

  6. Effect of a Clinical Pilates programme, as a tool in the field of Rehabilitation Nursing on Health-related quality of life (HRQoL) in people with COPD Gold A.

    EQ-5D-5L (Ferreira et al., 2023). Likert scale (1 to 5) self-assessment that considers 5 domains: * Mobility: from 'I have no mobility problems' to 'I am unable to walk'; * Personal care: 'I have no problems washing or dressing myself' to 'I am unable to wash or dress myself'; * Usual activities (e.g. domestic, leisure or family activities): 'I have no problem performing my usual activities' to 'I am unable to perform my usual activities'; * Pain/Discomfort: 'I have no pain or discomfort' to 'I have extreme pain or discomfort'; * Anxiety/Depression: 'I am not anxious and/or depressed' to 'I am extremely anxious and/or depressed'; * Visual scale from 0 to 100, where 0 is 'worst health imaginable' and 100 is 'best health imaginable.' The person is asked to place an X on the scale to indicate how they feel about their health at the moment.

    Time frame: Applied pre-intervention and post-intervention (with a 2-month interval). Both in Experimental and control group.

07

Study locations

1 site
  • Unidade de Cuidados na Comunidade de Guimarães
    Guimarães, 4800, Portugal
08

References and documents

Individual participant data

Plan to share: Yes

Supporting information: Study protocol, Csr

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 5, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07267858
Lead sponsor
University of Trás-os-Montes and Alto Douro
Collaborators
Unidade Local de Saúde do Alto Ave, EPE
Responsible party
Cristiana Marques (Enfermeira Cristiana Marques, University of Trás-os-Montes and Alto Douro) — Principal investigator
First posted
Dec 5, 2025
Start date
Nov 7, 2024
Primary completion
Nov 11, 2025
Completion
Jul 24, 2026 (estimated)
Last update
Dec 5, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Nov 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion